Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Medtech

 

Addressing healthcare workforce inefficiency through AI and 3d indoor mapping – a conversation with Connie Moser of Navenio

Modern hospitals are incredibly complex, regularly chaotic, and often inefficient environments, despite efficiency and proper task sequencing being vital to delivering high-quality medical care and positive patient experiences. Workforce issues are beginning to bite harder across both public and private provider systems, driven by a growing deficit in medical professionals serving an expanding patient population. […]

CVC Capital acquires major stake in Indonesia’s Siloam Hospitals, signalling rising PE interest in Southeast Asia healthcare

CVC Capital Partners, a Luxembourg-based private equity firm, has acquired an additional 45% stake in Indonesia's chain of multi speciality hospitals, Siloam Hospitals, from the country’s conglomerate Lippo Karawaci for 16.6 trillion rupiah ($1 billion), making CVC the majority shareholder. This transaction, involving 5.85 billion shares, was announced on the Indonesia Stock Exchange.

What innovations are health tech investors most excited about in 2024?

Healthcare is a sector in which it can be hard to innovate. Regulations are tight and risk aversion is rife. This is understandable — justifiable, even — given lives are at stake. But it means the sector doesn’t see much creative destruction in the models it uses for delivering care. 

Exploring ‘dark labs’, at-home testing potential, and the diagnostic lab sector’s consolidation at HBI 2024

The global laboratory diagnostics market has grown significantly, with research estimating its value at around USD $210.58 billion in 2023. It is expected to reach approximately USD $284.38 billion by 2033, expanding at a CAGR of 3.05% from 2024 to 2033. This growth is driven by rising chronic diseases, an ageing population, and the increasing demand for early diagnostics. At HBI 2024, the panel 'Laboratory Diagnostics – Growth Beyond Consolidation' brought together industry experts.

Healthcare investment “through the bottom of the cycle” — Goldberg (Rothschild)

At last year’s conference Hedley Goldberg, Managing Director at multinational investment bank Rothschild, predicted healthcare M&A activity would begin picking up again in Q4 2023 or Q1 2024. But we’re now halfway through 2024 and there are still very few deals above €500m taking place. Goldberg is confident, however, that we have now passed through the bottom of the cycle.

Interview: Mohit Kumar, Ultrahuman

Ultrahuman is a medtech company that provides cutting-edge health-monitoring tools. It currently has four products: a smart ring, a continuous glucose monitoring wearable, a device that monitors air quality in the home and a blood-testing product. 

EU’s AI Act gets the greenlight from the European Commission

Despite opposition, the AI Act seems to be ploughing ahead right on schedule. This week, two key groups of lawmakers - the European Commission's civil liberties (LIBE) and internal market (IMCO) committees - gave their overwhelming support for the new law, which should come into force this summer.

Find Us